chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Headache, Nasal congestion
Clinical narrative: Nausea; Body aches; Chills; Cough; Headache; Nasal congestion; Sinus pressure; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient was allergic to penicillin and sulfa based drugs. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ethinylestradiol/levonorgestrel (ORSYTHIA) taken for birth control from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), cephalexin (MANUFACTURER UNKNOWN) and prednisone (MANUFACTURER UNKNOWN) and experienced drug allergy. On 21Apr2021 at 12:00, the patient experienced nausea, body aches, chills, cough, headache, nasal congestion, sinus pressure and tiredness. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea, body aches, chills, cough, headache, nasal congestion, sinus pressure and tiredness was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Paranasal sinus discomfort
Clinical narrative: Nausea; Body aches; Chills; Cough; Headache; Nasal congestion; Sinus pressure; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient was allergic to penicillin and sulfa based drugs. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ethinylestradiol/levonorgestrel (ORSYTHIA) taken for birth control from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), cephalexin (MANUFACTURER UNKNOWN) and prednisone (MANUFACTURER UNKNOWN) and experienced drug allergy. On 21Apr2021 at 12:00, the patient experienced nausea, body aches, chills, cough, headache, nasal congestion, sinus pressure and tiredness. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea, body aches, chills, cough, headache, nasal congestion, sinus pressure and tiredness was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperaesthesia, Pain, SARS-CoV-2 test
Clinical narrative: Body aches; Sensitivity to touch; Chills; Minor headaches; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 21Apr2021 at 13:15 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included methylphenidate hydrochloride (CONCERTA), citalopram hydrobromide (CELEXA), calcium (MANUFACTURER UNKNOWN) and multivitamin; all for an unknown indication from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 13:15 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 22Apr2021 at 07:15, the patient experienced body aches, sensitivity to touch along with chills and minor headaches. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent lab tests and procedures, which included COVID-19 virus test (nasal swab) and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of event body aches, sensitivity to touch along with chills and minor headaches were unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pyrexia, Vomiting
Clinical narrative: Vomiting; Fever; Soreness; 12 hours after vaccination there was muscle soreness; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 21Apr2021 at 10:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported and it was not reported if the patient had allergies to medications, food, or other products. Concomitant medications included cyanocobalamin (B 12), zinc (MANUFACTURER UNKNOWN), fish oil (OMEGA 3), unspecified Multivitamin and Algae Oil ; all taken from an unknown date for an unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 13:00 as a single dose for COVID-19 immunisation. On 21Apr2021 at 22:30, 12 hours after vaccination, the patient experienced muscle soreness and on 22Apr2021 at 01:30, 15 hours after vaccination there was vomiting, fever and soreness that lasted for 12 hours. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event muscle soreness was recovered on an unknown date in Apr2021 and the clinical outcome of the events vomiting, fever and soreness was recovered on 22Apr2021 at 13:30.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Headache, Myalgia, Pyrexia
Clinical narrative: Headache; High Fever; Sore Muscles; Loss of appetite; Weakness; This is a spontaneous report from a non-contactable pharmacist, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and allergy to seafood. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid (VITAMIN C), zinc (MANUFACTURER UNKNOWN) and sitosterol (CHOLESTOFF); all for unknown indications from unknown dates and unknown if ongoing. On 10Apr2021, the patient experienced headache, high fever, sore muscles, loss of appetite and weakness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with paracetamol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, high fever, sore muscles, loss of appetite and weakness was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Migraine, Musculoskeletal stiffness, Neck pain
Clinical narrative: Neck pain; Stiff neck; Severe migraines; Dizzyness; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the right arm on 05Apr2021 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 19Apr2021, the patient experienced neck pain, stiff neck, severe migraines and dizziness. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events neck pain, stiff neck, severe migraines and dizziness were unknown at the time of the report.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Paraesthesia, Product administered at inappropriate site, Rash
Clinical narrative: Started 1-2 weeks after 1st shot vascular rash on arms and legs; Red splotches; Some tingling; Vaccine location: Left leg; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left leg on 25Mar2021 at 00:00 (at the age of 56-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 56-years-old), as a single dose for COVID-19 immunization. Medical history included rosacea, cured stage 1 melanoma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included nabumetone (MANUFACTURER UNKNOWN), cyclobenzaprine (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN) and vitamin d nos (VITAMIN D), from an unknown date for unknown indication and unknown if ongoing. The patient previously took pseudoephedrine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 01Apr2021 at 16:00, 1-2 weeks after 1st shot, the patient had vascular rash on arms and legs and some red splotches, some tingling, no hives, no itching and was still present on day 29 for 2nd vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of events vascular rash on arms and legs and some red splotches, some tingling were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling cold, Pain, Pain in extremity, Pyrexia
Clinical narrative: Arm was sore right before bedtime; Checked temperature at 1pm and it was 99.5; Woke up really cold and achey.; Woke up really cold and achey.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 21Apr2021 at 11:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included scalp psoriasis and COVID-19. The patient had known allergies to penicillin. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included topical treatment for scalp psoriasis from an unknown date and unknown if ongoing and vitamins (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 20:30, the patient experienced arm was sore right before bedtime. On an unknown date in Apr2021, the patient woke up and was really cold and achy and checked temperature at 13:00 and it was 99.5. On an unknown date in Apr2021, the patient underwent Body temperature and the result was 99.5 (Units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm was sore right before bedtime, was really cold and achy and checked temperature at 13:00 and it was 99.5 was not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Herpes zoster, Post herpetic neuralgia
Clinical narrative: began to have burning sensation on the left side of  upper body; Shingles; Postherpetic neuralgia; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 26Mar2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included desvenlafaxine succinate monohydrate (PRISTIQ) from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN4199) via an unspecified route of administration in the left arm on 04Mar2021 at 09:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. On 27Mar2021 at 03:30, with 24 hours the patient experienced burning sensation on the left side of upper body; the same side both vaccines were administered. On an unknown date in Mar2021 the patient experienced within 3 days developed what appeared to be shingles, went to the doctor and was diagnosed with shingles. After the rash went away on an unknown date in 2021 the patient experienced; was diagnosed with post herpetic neuralgia. Patient stated that she believed the shingles was a result of the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with medication (Names unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events burning sensation on the left side of upper body, shingles, after the rash went away was diagnosed with post herpetic neuralgia was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles on upper face and eye left side; This is a spontaneous report from a non-contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 03Mar2021 at 15:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included drug allergy to paracetamol (ACETAMINOPHEN). Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9809) via an unspecified route of administration in the left arm on 10Feb2021 at 18:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 06:00, the patient experienced shingles on upper face and eye - left side. The event resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles on upper face and eye left side was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Limb discomfort, Pelvic pain
Clinical narrative: Really bad back pains; Pain in the pelvis; Limbs felt heavy; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on an unknown date (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 21Apr2021 at 12:00, the patient woke up with really bad back pains and pain in the pelvis and the limbs felt heavy, the morning after getting the vaccine. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events really bad back pains, pain in the pelvis and limbs felt heavy were not resolved at the time of the report.   No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urine present, Chills, Chromaturia, Fatigue, Laboratory test
Clinical narrative: started peeing out blood. It was pink.; had chills; low fever; fatigue; urine was a strange color; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EB8735) via an unspecified route of administration in the left arm on 19Apr2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. On 18Nov2020, the patient underwent lab tests and investigations that included PCR test for COVID-19 (Nasal Swab) and tested negative. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 17:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 15:00, the next day the patient's urine was a strange color, until the following day on 21Apr2021, the patient started peeing out blood which was pink. The patient reported that she was being tested for urinary tract infection (UTI) but did not have any UTI symptoms. On 20Apr2021 at 15:00, the day after the vaccine, the patient experienced chills, low fever and fatigue but on 21Apr2021, the patient had fully recovered. As of 22Apr2021, there was still blood in the urine. The patient reported that she had no history of any health concerns. On 21Apr2021, the patient underwent lab tests and investigations that included unspecified lab test for UTI and the results were unknown. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the reported events. The clinical outcome of the events chills, low fever and fatigue was recovered on 21Apr2021 while the outcome of the events urine was a strange color and blood in urine was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: started peeing out blood. It was pink.; had chills; low fever; fatigue; urine was a strange color; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EB8735) via an unspecified route of administration in the left arm on 19Apr2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. On 18Nov2020, the patient underwent lab tests and investigations that included PCR test for COVID-19 (Nasal Swab) and tested negative. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 17:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 15:00, the next day the patient's urine was a strange color, until the following day on 21Apr2021, the patient started peeing out blood which was pink. The patient reported that she was being tested for urinary tract infection (UTI) but did not have any UTI symptoms. On 20Apr2021 at 15:00, the day after the vaccine, the patient experienced chills, low fever and fatigue but on 21Apr2021, the patient had fully recovered. As of 22Apr2021, there was still blood in the urine. The patient reported that she had no history of any health concerns. On 21Apr2021, the patient underwent lab tests and investigations that included unspecified lab test for UTI and the results were unknown. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the reported events. The clinical outcome of the events chills, low fever and fatigue was recovered on 21Apr2021 while the outcome of the events urine was a strange color and blood in urine was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Tinnitus
Clinical narrative: Tinnitus; Coughing; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Apr2021 at 16:00 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 21Apr2021 at 12:00 the patient experienced tinnitus and coughing. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events tinnitus and coughing were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Eye swelling
Clinical narrative: Right eye is swollen; Eye is swollen. Tender to touch; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 20Apr2021 at 10:15 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline hydrochloride (ZOLOFT) and doxycycline (MANUFACTURER UNKNOWN); all from an unknown date and for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FR8727) via an unspecified route of administration in the left arm on 20Mar2021 at 10:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Apr2021 at 07:00, the patient experienced swollen right eye which was tender to touch. Since the vaccination, the patient had not been tested for COVID-19. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events swollen right eye and tender was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in both ears; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO153) via an unspecified route of administration in the left arm on 12Apr2021 at 09:15 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 22Mar2021 at 15:15 (age at vaccination unknown) as a single dose for COVID-19 immunisation. On 12Apr2021 at 10:00, the patient experienced ringing in both ears. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event ringing in both ears was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Dehydration, Disturbance in attention, Dizziness, Ear discomfort
Clinical narrative: Plugged/whooshing/ringing/popping ears; Pressure in head; Hands and feet get cold; Inability to concentrate; Foggy brain; Constant sinus drainage; Occasional sneezing; Dehydration; Dizziness; My hands and feet get cold they hurt; Vivid dreams; Popping ears; During meetings I find myself starting sentences but I cant finish them,; Insomnia; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 41-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced plugged/whooshing/ringing/popping ears, pressure in head, dizziness, especially when looked up after looking down at phone, hands and feet got so cold they hurt. The patient could put frozen feet by space heater and they did not warm up, they just hurt more, inability to concentrate and foggy brain. During meetings, the patient found herself starting sentences but she could not finish them, it was like she stopped and waited for her friends/family/co-workers to finish her thoughts. Other symptoms that did not bother her as much. Constant sinus drainage, occasional sneezing, dehydration, insomnia, vivid dreams and dizziness. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the event plugged/whooshing/ringing/popping ears, pressure in head, dizziness, especially when looked up after looking down at phone, hands and feet got so cold they hurt, inability to concentrate and foggy brain, constant sinus drainage, occasional sneezing, dehydration, insomnia, vivid dreams and dizziness were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Head discomfort, Insomnia, Pain in extremity, Peripheral coldness
Clinical narrative: Plugged/whooshing/ringing/popping ears; Pressure in head; Hands and feet get cold; Inability to concentrate; Foggy brain; Constant sinus drainage; Occasional sneezing; Dehydration; Dizziness; My hands and feet get cold they hurt; Vivid dreams; Popping ears; During meetings I find myself starting sentences but I cant finish them,; Insomnia; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 41-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced plugged/whooshing/ringing/popping ears, pressure in head, dizziness, especially when looked up after looking down at phone, hands and feet got so cold they hurt. The patient could put frozen feet by space heater and they did not warm up, they just hurt more, inability to concentrate and foggy brain. During meetings, the patient found herself starting sentences but she could not finish them, it was like she stopped and waited for her friends/family/co-workers to finish her thoughts. Other symptoms that did not bother her as much. Constant sinus drainage, occasional sneezing, dehydration, insomnia, vivid dreams and dizziness. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the event plugged/whooshing/ringing/popping ears, pressure in head, dizziness, especially when looked up after looking down at phone, hands and feet got so cold they hurt, inability to concentrate and foggy brain, constant sinus drainage, occasional sneezing, dehydration, insomnia, vivid dreams and dizziness were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus operation, Sneezing, Speech disorder, Tinnitus
Clinical narrative: Plugged/whooshing/ringing/popping ears; Pressure in head; Hands and feet get cold; Inability to concentrate; Foggy brain; Constant sinus drainage; Occasional sneezing; Dehydration; Dizziness; My hands and feet get cold they hurt; Vivid dreams; Popping ears; During meetings I find myself starting sentences but I cant finish them,; Insomnia; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 41-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced plugged/whooshing/ringing/popping ears, pressure in head, dizziness, especially when looked up after looking down at phone, hands and feet got so cold they hurt. The patient could put frozen feet by space heater and they did not warm up, they just hurt more, inability to concentrate and foggy brain. During meetings, the patient found herself starting sentences but she could not finish them, it was like she stopped and waited for her friends/family/co-workers to finish her thoughts. Other symptoms that did not bother her as much. Constant sinus drainage, occasional sneezing, dehydration, insomnia, vivid dreams and dizziness. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the event plugged/whooshing/ringing/popping ears, pressure in head, dizziness, especially when looked up after looking down at phone, hands and feet got so cold they hurt, inability to concentrate and foggy brain, constant sinus drainage, occasional sneezing, dehydration, insomnia, vivid dreams and dizziness were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain of skin, Skin warm, Urticaria
Clinical narrative: Welts all over my body.; skin hurts, feels pricey; skin feels pricey and hot. All over body, face, head; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 12:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 (also reported as 15Apr2021), the patient experienced welts all over the body, her skin hurts, her skin feels pricey and hot, all over body, face and head. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events Welts all over my body, her skin hurts, her skin feels pricey and hot, all over body, face and head were resolving at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Chest pain, Cough, Dermatitis, Discomfort
Clinical narrative: Coughing fit; Burning in chest and on breasts which felt like jalepeno had been rubbed all within lungs and on breasts.; Burning in chest and on breasts which felt like jalepeno had been rubbed all within lungs and on breasts.; So uncomfortable; Breasts was very red and streaky; Rashes; Skin inflammation; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 20Apr2021 at 09:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and multivitamins (MANUFACTURER UNKNOWN); both from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 30Mar2021 at 11:00 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. On 20Apr2021 at 12:00, within about 2 hours after the vaccination, the patient experienced coughing fit (which the patient had already been having due to allergies). The patient had a burning in chest and on the breasts which felt like jalepeno had been rubbed all within lungs and on the breasts. The patient was so uncomfortable. It was reported that the patient stripped down and saw that the breasts were very red and streaky. The coughing and burning sensations have occurred 4 times, but the patient had not noticed any more rashes or skin inflammation. The patient's left side was definitely more affected than the right. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events coughing fit, burning in chest and on breasts which felt like jalepeno had been rubbed all within lungs and on breasts, so uncomfortable, breasts was very red and streaky, rashes and skin inflammation were unknown at the time of reporting.    No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash
Clinical narrative: Coughing fit; Burning in chest and on breasts which felt like jalepeno had been rubbed all within lungs and on breasts.; Burning in chest and on breasts which felt like jalepeno had been rubbed all within lungs and on breasts.; So uncomfortable; Breasts was very red and streaky; Rashes; Skin inflammation; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 20Apr2021 at 09:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and multivitamins (MANUFACTURER UNKNOWN); both from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 30Mar2021 at 11:00 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. On 20Apr2021 at 12:00, within about 2 hours after the vaccination, the patient experienced coughing fit (which the patient had already been having due to allergies). The patient had a burning in chest and on the breasts which felt like jalepeno had been rubbed all within lungs and on the breasts. The patient was so uncomfortable. It was reported that the patient stripped down and saw that the breasts were very red and streaky. The coughing and burning sensations have occurred 4 times, but the patient had not noticed any more rashes or skin inflammation. The patient's left side was definitely more affected than the right. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events coughing fit, burning in chest and on breasts which felt like jalepeno had been rubbed all within lungs and on breasts, so uncomfortable, breasts was very red and streaky, rashes and skin inflammation were unknown at the time of reporting.    No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Nausea, Pain
Clinical narrative: Body aches; Malaise; Fatigue; Low-grade fever; Headaches; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 01Apr2021 at 12:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, psoriasis, gastroesophageal reflux disease (GERD), type 2 diabetes mellitus and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN) and vitamins nos/ minerals nos (CENTRUM); all for unknown indication from unknown date and unknown if ongoing. On 03Apr2021 at 20:00, the patient experienced fatigue, body aches, low-grade fever, headaches, nausea and malaise. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue, body aches, low-grade fever, headaches, nausea and malaise were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body aches; Malaise; Fatigue; Low-grade fever; Headaches; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 01Apr2021 at 12:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, psoriasis, gastroesophageal reflux disease (GERD), type 2 diabetes mellitus and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN) and vitamins nos/ minerals nos (CENTRUM); all for unknown indication from unknown date and unknown if ongoing. On 03Apr2021 at 20:00, the patient experienced fatigue, body aches, low-grade fever, headaches, nausea and malaise. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue, body aches, low-grade fever, headaches, nausea and malaise were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node under left armpit; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 00:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included duchenne muscular dystrophy (reported as duchenne). The patient had known allergy to mango. The patient previously took sulfamethoxazole (MANUFACTURER UNKNOWN) and amoxicillin (MANUFACTURER UNKNOWN) for unknown indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included pregabalin (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and amitriptyline (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates and unknown if ongoing. On 21Apr2021 at 16:00, the patient experienced swollen lymph node under left armpit. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swollen lymph node under left armpit was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.